KONINKLIJKE PHILIPS NV financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data KONINKLIJKE PHILIPS NV files with the SEC in its annual reports.

In EUR millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	17,422	17,780	18,121	17,147	17,313	17,156	17,827	18,169	18,021	17,834
Cost of revenue	9,484	9,600	9,568	9,249	9,493	9,988	10,633	10,721	10,248	9,776
Gross profit	7,939	8,181	8,554	7,899	7,820	7,168	7,194	7,448	7,773	8,058
Research and development	1,669	1,764	1,759	1,790	1,822	1,806	2,091	1,890	1,747	1,700
Selling and marketing	4,142	4,398	4,500	4,125	4,054	4,258	4,621	4,524	4,486	4,342
Operating income	1,464	1,517	1,719	1,366	1,264	553	-1,529	-115	529	1,424
Interest expense	507	263	264	233	202	188	258	376	387	346
Interest income	65	126	51	114	158	149	58	63	105	113
Pre-tax income	1,034	1,377	1,503	1,248	1,211	509	-1,731	-526	123	1,182
Income tax	203	349	193	258	212	-103	-113	-73	963	282
Income from continuing operations	831	1,028	1,310	990	999	612	-1,618	-454	-840	901
Net income to minority interests	43	214	7	5	8	4	3	2	3	1
Net income	1,448	1,657	1,090	1,167	1,187	3,319	-1,608	-466	-702	895
EBITDA	2,440	2,542	2,808	2,709	2,726	1,876	73	1,146	1,919	2,549
EPS, basic	1.52	1.71	1.11	1.22	1.26	3.52	-1.69	-0.49	-0.75	0.94
EPS, diluted	1.50	1.68	1.09	1.20	1.24	3.50	-1.69	-0.49	-0.75	0.93

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	2,334	1,939	1,688	1,425	3,226	2,303	1,172	1,869	2,401	2,794
Receivables	5,327	3,909	4,035	4,554	4,156	3,787	4,115	3,733	3,672	3,530
Inventory	3,392	2,353	2,674	2,773	2,993	3,450	4,049	3,491	3,198	2,870
Total current assets	14,075	10,117	9,572	9,459	11,227	10,347	10,259	9,940	10,022	9,932
Property, plant and equipment	2,155	1,591	1,712	2,866	2,682	2,699	2,638	2,483
Goodwill	8,898	7,731	8,503	8,654	8,014	10,637	10,238	9,876	10,383	9,271
Intangible assets	3,552	3,322	3,589	3,466	2,997	3,650	3,526	3,190	2,982	2,569
Total assets	32,270	25,315	26,019	27,016	27,713	30,961	30,688	29,406	28,976	26,944
Accounts payable	2,848	2,090	2,303	2,089	2,119	1,872	1,968	1,917	1,830	1,927
Short-term debt								122	92	52
Total current liabilities	10,473	6,866	7,943	6,978	7,735	7,450	7,934	8,287	8,146	7,509
Lease liabilities			892
Total liabilities	18,817	13,322	13,935	14,391	15,812	16,486	17,405	17,345	16,933	15,954
Total debt	5,606	4,715	4,821	5,447	6,934	6,980	8,201	7,689	7,639	8,084
Paid-in capital						4,646	5,025	5,827	6,654
Retained earnings			8,266
Shareholders' equity	12,546	11,999	12,088	12,597	11,870	14,438	13,249	12,028	12,006	10,957
Minority interests	907	24	29	28	31	36	34	33	37	32
Total equity	13,453	11,993	12,084	12,625	11,901	14,475	13,283	12,061	12,043	10,990
Total liabilities and equity	32,270	25,315	26,019	27,016	27,713	30,961	30,688	29,406	28,976	26,944

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	1,491	1,870	1,097	1,173	1,195	3,323	-1,605	-463	-698	897
Depreciation and amortization	976	1,025	1,089	1,343	1,462	1,323	1,602	1,261	1,390	1,125
Capital expenditures	360	-420	-422	-486	-485	-397	-444	-345	-317	-269
Debt issued	123	1,115	1,287	847	1,065	76	2,516	544	710	1,057
Debt repaid	357	-1,332	-1,161	-756	-298	-302	-1,472	-754	-763	-609
Stock issued	80	227	94	58	46	23
Share buybacks	606	-642	-1,042	-1,376	-343	-1,636	-187	-662	-411	0
Dividends paid					-26	-484	-418	-70	-32	-330
Exchange rate effect	-17	-184	0	-2	-55	65	41	-79	45	-139
Interest paid	296	215	170	171	148	151	205	250	261	253
Income taxes paid	-295	284	301	354	390	249	333	152	173	213

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.

Profitability

Metric	Value	How it is calculated
Gross margin	45.2%	Gross profit / revenue.
Operating margin	8.0%	Operating income / revenue.
EBITDA margin	14.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	6.6%	Pre-tax income / revenue.
Net margin	5.0%	Net income / revenue.
Effective tax rate	23.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	7.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.2%	Net income / average total assets.
Return on invested capital (ROIC)	6.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	9.5%	Research and development expense / revenue.
Capex / revenue	1.5%	Capital expenditures / revenue.
D&A / revenue	6.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-1.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	0.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	3.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	3.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	0.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	169.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y	2.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	32.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	226.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-1.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 5y	-5.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 5y	-5.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-8.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-6.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-1.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-7.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-0.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.32x	Current assets / current liabilities.
Quick ratio	0.84x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.37x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.74x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	30.0%	Total debt / total assets.
Liabilities / assets	59.2%	Total liabilities / total assets.
Net debt	€5.29B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.08x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	4.12x	Operating income / interest expense.
Working capital	€2.42B	Current assets - current liabilities.
Goodwill and intangibles / assets	43.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-€883.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.64x	Revenue / average total assets.
Inventory turnover	3.22x	Cost of revenue / average inventory.
Days inventory	113 days	365 x average inventory / cost of revenue.
Receivables turnover	4.95x	Revenue / average receivables.
Days sales outstanding	74 days	365 x average receivables / revenue.
Days payables	70 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	117 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	€0.93	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	€0.94	Net income per basic share, as reported (split-adjusted).
Payout ratio	36.9%	Dividends paid / net income, when net income is positive.

What was KONINKLIJKE PHILIPS NV's revenue in fiscal 2025?

KONINKLIJKE PHILIPS NV reported revenue of €17.83B for fiscal 2025, 1% lower than the year before.

Was KONINKLIJKE PHILIPS NV profitable in fiscal 2025?

Yes. Net income was €895.0M, a net margin of 5%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to KONINKLIJKE PHILIPS NV